CPB Stock Analysis: Campbell’s | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.170m USD | 12M Return: -36% | US1344291091 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 158M
EPS Trend: -71.3%
Qual. Beats: 0
Rev. Trend: 67.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Campbells Company (NASDAQ: CPB) is a U.S.-based packaged food manufacturer operating through two segments: Meals & Beverages, and Snacks. The Meals & Beverages segment sells soups, broths, sauces, juices, and frozen entrées under brands such as Campbells, Swanson, Pacific Foods, Prego, Pace, V8, Raos, and Michael Angelos, primarily in the U.S. and Canada. The Snacks segment markets cookies, crackers, pretzels, and chips through brands including Pepperidge Farm, Goldfish, Snyders of Hanover, Lance, Cape Cod, Kettle Brand, and Late July, with additional retail operations in Latin America.
Products are distributed through retail food chains, mass discounters, club stores, convenience and dollar stores, e-commerce platforms, and foodservice operators, as well as via independent contractor distributors. The company was founded in 1869, is headquartered in Camden, New Jersey, and rebranded from Campbell Soup Company to The Campbells Company in November 2024.
As a mid-cap stock in the Packaged Foods & Meats sub-industry of Consumer Staples, Campbells operates in a defensive sector characterized by relatively stable consumer demand and brand-driven pricing, with revenue split between retail shelf-stable products and higher-margin snacking categories.
- Raos premium pasta sauce sales accelerate post-Sovos acquisition
- Snacks segment volume softens as center-store demand normalizes
- Input cost inflation and acquisition debt pressure profit margins
| Net Income: 403.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.40 > 1.0 |
| NWC/Revenue: -6.32% < 20% (prev -6.57%; Δ 0.25% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.04b > Net Income 403.0m |
| Net Debt (7.17b) to EBITDA (1.26b): 5.67 < 3 |
| Current Ratio: 0.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (300.0m) vs 12m ago 0.33% < -2% |
| Gross Margin: 28.14% > 18% (prev 30.42%; Δ -2.28% > 0.5%) |
| Asset Turnover: 63.80% > 50% (prev 68.83%; Δ -5.03% > 0%) |
| Interest Coverage Ratio: 2.64 > 6 (EBIT TTM 852.0m / Interest Expense TTM 323.0m) |
| A: -0.04 (Total Current Assets 2.72b - Total Current Liabilities 3.34b) / Total Assets 15.6b |
| B: 0.30 (Retained Earnings 4.62b / Total Assets 15.6b) |
| C: 0.06 (EBIT TTM 852.0m / Avg Total Assets 15.3b) |
| D: 0.34 (Book Value of Equity 3.85b / Total Liabilities 11.5b) |
| Altman-Z'' = 1.43 = BB |
| DSRI: 1.04 (Receivables 578.0m/583.0m, Revenue 9.74b/10.3b) |
| GMI: 1.08 (GM 30.42% / 28.14%) |
| AQI: 1.00 (AQ_t 0.64 / AQ_t-1 0.64) |
| SGI: 0.95 (Revenue 9.74b / 10.3b) |
| TATA: -0.04 (NI 403.0m - CFO 1.04b) / TA 15.6b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 19.37 with a total of 7,905,780 shares traded. Over the past week, the price has changed by -6.38%, over one month by -17.47%, over three months by -11.87% and over the past year by -36.04%.
Current recommended Stop Loss: 18.30 (which is 5.5% or 1.5 ATR below the current price).
Campbell’s has received a consensus analysts rating of 2.84. Therefore, it is recommended to hold CPB.
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 3
- StrongSell: 2
| Analysts Target Price | 20.8 | 7.3% |
P/E Trailing = 15.7939
P/E Forward = 12.3457
P/S = 0.6332
P/B = 1.6397
P/EG = 0.5462
Revenue TTM = 9.74b USD
EBIT TTM = 852.0m USD
EBITDA TTM = 1.26b USD
Long Term Debt = 6.15b USD (from longTermDebt, two quarters ago)
Short Term Debt = 977.0m USD (from shortTermDebt, last quarter)
Debt = 7.56b USD (from shortLongTermDebtTotal, last quarter) + Leases 425.0m
Net Debt = 7.17b USD (calculated: Debt 7.56b - CCE 394.0m)
Enterprise Value = 13.3b USD (6.17b + Debt 7.56b - CCE 394.0m)
Interest Coverage Ratio = 2.64 (Ebit TTM 852.0m / Interest Expense TTM 323.0m)
EV/FCF = 19.67x (Enterprise Value 13.3b / FCF TTM 678.0m)
FCF Yield = 5.08% (FCF TTM 678.0m / Enterprise Value 13.3b)
FCF Margin = 6.96% (FCF TTM 678.0m / Revenue TTM 9.74b)
Net Margin = 4.14% (Net Income TTM 403.0m / Revenue TTM 9.74b)
Gross Margin = 28.14% ((Revenue TTM 9.74b - Cost of Revenue TTM 7.00b) / Revenue TTM)
Gross Margin QoQ = 27.28% (prev 27.47%)
Tobins Q-Ratio = 0.85 (Enterprise Value 13.3b / Total Assets 15.6b)
Interest Expense / Debt = 4.27% (Interest Expense 323.0m / Debt 7.56b)
Taxrate = 23.44% (124.0m / 529.0m)
NOPAT = 652.3m (EBIT 852.0m * (1 - 23.44%))
Current Ratio = 0.82 (Total Current Assets 2.72b / Total Current Liabilities 3.34b)
Debt / Equity = 1.96 (Debt 7.56b / totalStockholderEquity, last quarter 3.85b)
Debt / EBITDA = 5.67 (Net Debt 7.17b / EBITDA 1.26b)
Debt / FCF = 10.57 (Net Debt 7.17b / FCF TTM 678.0m)
Total Stockholder Equity = 3.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.64% (Net Income 403.0m / Total Assets 15.6b)
RoE = 10.18% (Net Income TTM 403.0m / Total Stockholder Equity 3.96b)
RoCE = 8.43% (EBIT 852.0m / Capital Employed (Equity 3.96b + L.T.Debt 6.15b))
RoIC = 5.06% (NOPAT 652.3m / Invested Capital 12.9b)
WACC = 4.25% (E(6.17b)/V(13.7b) * Re(5.45%) + D(7.56b)/V(13.7b) * Rd(4.27%) * (1-Tc(0.23)))
Discount Rate = 5.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.69 | Cagr: 0.0%
[DCF] Terminal Value 74.91% ; FCFF base≈688.8m ; Y1≈669.5m ; Y5≈664.5m
[DCF] Fair Price = 10.87 (EV 10.4b - Net Debt 7.17b = Equity 3.24b / Shares 298.2m; r=8.35% [WACC [floored]]; 5y FCF grow -3.83% → 2.50% )
EPS Correlation: -71.27 | EPS CAGR: -8.22% | SUE: -0.26 | # QB: 0
Revenue Correlation: 67.71 | Revenue CAGR: 2.78% | SUE: -0.23 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.41 | Chg30d=-30.98% | Revisions=-67% | Analysts=16
EPS next Quarter (2027-01-31): EPS=0.42 | Chg30d=-8.23% | Revisions=-67% | Analysts=16
EPS current Year (2027-07-31): EPS=1.70 | Chg30d=-12.19% | Revisions=-85% | GrowthEPS=-21.8% | GrowthRev=-2.5%
EPS next Year (2028-07-31): EPS=1.84 | Chg30d=-12.37% | Revisions=-75% | GrowthEPS=+8.2% | GrowthRev=-0.3%
[Analyst] Revisions Ratio: -87% (up=2, down=48)